[Role of Pseudomonas aeruginosa in the etiology of infectious complications in cancer patients].
The occurrence of Pseudomonas aeruginosa in various pathologic materials and feces from patients with different cancer was compared. The rate of Pseudomonas aeruginosa-associated postoperative complications versus the frequency of intraoperative detection of the organism was studied. The sensitivity of Pseudomonas aeruginosa to antibacterial drugs was assessed. Serotypes of 480 strains isolated from patients and environment were identified. It was inferred that exogenous contamination from the external environment accounts for the majority of cases of Pseudomonas aeruginosa-associated complications.
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D005770:Gastrointestinal Neoplasms / Q000150:complications / Q000601:surgery; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000601:surgery; D011183:Postoperative Complications; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000453:epidemiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents
Rol' sinegnoĭnykh bakteriĭ v razvitii infektsionnykh oslozhneniĭ u onkologicheskikh bol'nykh.